Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | ARDX | SPRY | ||
| Company | Enliven Therapeutics Inc | Ardelyx Inc | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 22.51 | 4.63 | 11.18 | ||
| High | 22.99 | 4.96 | 11.56 | ||
| Low | 21.83 | 4.58 | 10.83 | ||
| Last | 22.47 | 4.82 | 11.18 | ||
| Change | -0.40 | +0.13 | -0.14 | ||
| % Change | -1.75% | +2.77% | -1.24% | ||
| Volume | 395,200 | 5,041,700 | 2,578,100 | ||
| 20-Day Average Volume | 204,655 | 4,024,600 | 1,121,855 | ||
| Previous Close | 22.87 | 4.69 | 11.32 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.91 | 5.28 | 13.03 | ||
| 20-Day Raw Stochastic | 17.73% | 32.26% | 12.88% | ||
| 20-Day Relative Strength | 40.93% | 42.25% | 36.51% | ||
| Weighted Alpha | -0.41 | -42.14 | +63.40 | ||
| Today's Opinion | 24% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 8% Sell | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 56% Buy | 88% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.94% since 12/13/24 | -7.66% since 12/13/24 | -6.05% since 12/13/24 | ||
| Low | 21.83 on 12/20/24 | 4.32 on 12/18/24 | 10.63 on 12/18/24 | ||
| High | 24.42 on 12/17/24 | 5.47 on 12/17/24 | 12.39 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -11.64% since 11/20/24 | -2.03% since 11/20/24 | -17.49% since 11/20/24 | ||
| Low | 21.69 on 12/12/24 | 4.32 on 12/18/24 | 10.63 on 12/18/24 | ||
| High | 26.09 on 11/22/24 | 5.87 on 12/06/24 | 14.90 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | -3.10% since 09/20/24 | -21.37% since 09/20/24 | -24.31% since 09/20/24 | ||
| Low | 21.69 on 12/12/24 | 4.32 on 12/18/24 | 10.63 on 12/18/24 | ||
| High | 30.03 on 10/18/24 | 7.18 on 09/27/24 | 18.51 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +6.80% since 06/20/24 | -18.17% since 06/20/24 | +44.63% since 06/20/24 | ||
| Low | 19.88 on 06/26/24 | 4.32 on 12/18/24 | 7.55 on 06/25/24 | ||
| High | 30.03 on 10/18/24 | 8.06 on 07/01/24 | 18.51 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,097,862 | 1,141,636 | 1,086,528 | ||
| Shares Outstanding, K | 48,859 | 236,854 | 97,185 | ||
| Annual Sales | 0 | 124,460,000 | 30,000 | ||
| Annual Net Income | -71,580,000 | -66,070,000 | -54,370,000 | ||
| Last Quarter Sales | 0 | 98,240,000 | 2,070,000 | ||
| Last Quarter Net Income | -23,160,000 | -810,000 | -19,130,000 | ||
| 60-Month Beta | 1.02 | 0.83 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 11/13/24 | 0.00 on 10/31/24 | -0.20 on 11/13/24 | ||
| Latest Earnings Date | 11/14/24 | 10/31/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||